Antibody responses to envelope glycoproteins in HIV-1 infection.

Articles citing Antibody responses to envelope glycoproteins in HIV-1 infection.

Title / Author	Year
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade N McGranahan, AJS Furness, R Rosenthal, S Ramskov, R Lyngaa, ... Science 351 (6280), 1463-1469	2016
Broadly neutralizing antibodies to HIV and their role in vaccine design DR Burton, L Hangartner Annual review of immunology 34, 635-659	2016
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection RM Lynch, E Boritz, EE Coates, A DeZure, P Madden, P Costner, ... Science translational medicine 7 (319), 319ra206-319ra206	2015
Effect of HIV antibody VRC01 on viral rebound after treatment interruption KJ Bar, MC Sneller, LJ Harrison, JS Justement, ET Overton, ME Petrone, ... New England Journal of Medicine 375 (21), 2037-2050	2016
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges R Gautam, Y Nishimura, A Pegu, MC Nason, F Klein, A Gazumyan, ... Nature 533 (7601), 105-109	2016
Antibody 10-1074 suppresses viremia in HIV-1-infected individuals M Caskey, T Schoofs, H Gruell, A Settler, T Karagounis, EF Kreider, ... Nature medicine 23 (2), 185-191	2017
HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen JG Jardine, DW Kulp, C Havenar-Daughton, A Sarkar, B Briney, D Sok, ... Science 351 (6280), 1458-1463	2016
Broadly neutralizing antibody responses in a large longitudinal sub-Saharan HIV primary infection cohort E Landais, X Huang, C Havenar-Daughton, B Murrell, MA Price, ... PLoS pathogens 12 (1), e1005369	2016
Identification of a CD4-binding-site antibody to HIV that evolved near-pan neutralization breadth J Huang, BH Kang, E Ishida, T Zhou, T Griesman, Z Sheng, F Wu, ... Immunity 45 (5), 1108-1121	2016
Affinity maturation of a potent family of HIV antibodies is primarily focused on accommodating or avoiding glycans F Garces, JH Lee, N de Val, AT de la Pena, L Kong, C Puchades, Y Hua, ... Immunity 43 (6), 1053-1063	2015
Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design R Rappuoli, MJ Bottomley, U D’Oro, O Finco, E De Gregorio Journal of Experimental Medicine 213 (4), 469-481	2016
The HIV‐1 envelope glycoprotein structure: Nailing down a moving target AB Ward, IA Wilson Immunological reviews 275 (1), 21-32	2017
CXCL13 is a plasma biomarker of germinal center activity C Havenar-Daughton, M Lindqvist, A Heit, JE Wu, SM Reiss, K Kendric, ... Proceedings of the National Academy of Sciences 113 (10), 2702-2707	2016
HIV infection SG Deeks, J Overbaugh, A Phillips, S Buchbinder Nature reviews Disease primers 1 (1), 1-22	2015
Elimination of HIV-1-infected cells by broadly neutralizing antibodies T Bruel, F Guivel-Benhassine, S Amraoui, M Malbec, L Richard, K Bourdic, ... Nature communications 7 (1), 1-12	2016
Native‐like Env trimers as a platform for HIV‐1 vaccine design RW Sanders, JP Moore Immunological reviews 275 (1), 161-182	2017
Holes in the glycan shield of the native HIV envelope are a target of trimer-elicited neutralizing antibodies LE McCoy, MJ van Gils, G Ozorowski, T Messmer, B Briney, JE Voss, ... Cell reports 16 (9), 2327-2338	2016
Open and closed structures reveal allostery and pliability in the HIV-1 envelope spike G Ozorowski, J Pallesen, N de Val, D Lyumkis, CA Cottrell, JL Torres, ... Nature 547 (7663), 360-363	2017
New member of the V1V2-directed CAP256-VRC26 lineage that shows increased breadth and exceptional potency NA Doria-Rose, JN Bhiman, RS Roark, CA Schramm, J Gorman, ... Journal of virology 90 (1), 76-91	2016
Envelope residue 375 substitutions in simian–human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques H Li, S Wang, R Kong, W Ding, FH Lee, Z Parker, E Kim, GH Learn, ... Proceedings of the National Academy of Sciences 113 (24), E3413-E3422	2016

1 - 20

Dates and citation counts are estimated and are determined automatically by a computer program.